Markets:

Overview

News

Currencies

International

Treasuries

Immuneering Corporation - Class A Common Stock (NQ:IMRX)

4.135 -0.085 (-2.01%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immuneering Corporation - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Immuneering Presents Preclinical Data with Lead Program IMM-1-104 Supporting Universal-RAS Activity

March 05, 2023

From Immuneering Corporation

Via GlobeNewswire

Immuneering Earnings Preview ↗

March 03, 2023

Via Benzinga

Immuneering Announces Participation in March Investor Conferences

February 28, 2023

From Immuneering Corporation

Via GlobeNewswire

Immuneering to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates

February 27, 2023

Management to host conference call on Monday, March 6 at 4:30 p.m. ET

From Immuneering Corporation

Via GlobeNewswire

Immuneering's Return On Capital Employed Insights ↗

December 20, 2022

Via Benzinga

Why This Small-Cap Stock Is Gaining More Than 10% Today? ↗

July 08, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023 ↗

February 03, 2023

Via Benzinga

Immuneering To Present at Guggenheim 2023 Oncology Conference

January 31, 2023

From Immuneering Corporation

Via GlobeNewswire

Immuneering Announces First Patient Dosed in its Phase 1/2a Clinical Trial of IMM-1-104 in Advanced Solid Tumors with RAS Mutations

November 28, 2022

From Immuneering Corporation

Via GlobeNewswire

Immuneering Presents Promising Preclinical Data on its Second Program IMM-6-415 at the 37th Annual Meeting of SITC

November 10, 2022

From Immuneering Corporation

Via GlobeNewswire

Immuneering Reports Third Quarter 2022 Financial Results and Recent Business Highlights

November 10, 2022

From Immuneering Corporation

Via GlobeNewswire

Immuneering Announces Participation in November Investor Conferences

November 03, 2022

From Immuneering Corporation

Via GlobeNewswire

Immuneering Appoints Leah R. Neufeld as Chief People Officer

October 20, 2022

From Immuneering Corporation

Via GlobeNewswire

Immuneering To Present Poster on IMM-6-415 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

October 05, 2022

From Immuneering Corporation

Via GlobeNewswire

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday ↗

September 30, 2022

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Immuneering Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of IMM-1-104 to Treat Advanced Solid Tumors with RAS Mutations

September 30, 2022

Initiation of Phase 1/2a Clinical Trial Expected to Occur in Q4 2022

From Immuneering Corporation

Via GlobeNewswire

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗

September 14, 2022

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 06, 2022

Gainers Metacrine (NASDAQ:MTCR) shares rose 13.8% to $0.54 during Tuesday's after-market session. This security traded at a volume of 3.0 million shares come close, making up 948.6% of its average...

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

September 02, 2022

Via Benzinga

Immuneering Shares Climb After Pursuing FDA Nod For RAS Mutant Tumor Study ↗

September 02, 2022

Immuneering (NASDAQ: IMRX) submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its product candidate IMM-1-104 in development for the treatment of...

Via Benzinga

Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday ↗

September 02, 2022

Gainers

Via Benzinga

Tesla, Twitter And 76 Biggest Movers From Friday ↗

July 11, 2022

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022 ↗

July 08, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 24, 2022

Via Benzinga

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

55 Biggest Movers From Friday ↗

April 04, 2022

Gainers Takung Art Co., Ltd. (NASDAQ: TKAT) surged 61.8% to close at $3.64 on Friday. Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: CSSE) rose 43.8% to settle at $11.49...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022 ↗

April 01, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.